These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 17287171

  • 1. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [Abstract] [Full Text] [Related]

  • 2. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ, Zhao ZM, Fu JY, Chen CQ, Sun W.
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [Abstract] [Full Text] [Related]

  • 3. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):603-7. PubMed ID: 15567755
    [Abstract] [Full Text] [Related]

  • 4. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
    Fan YZ, Zhao ZM, Fu JY, Chen CQ.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):618-22. PubMed ID: 16784656
    [Abstract] [Full Text] [Related]

  • 5. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    Zhonghua Zhong Liu Za Zhi; 2004 May 01; 26(5):271-4. PubMed ID: 15312360
    [Abstract] [Full Text] [Related]

  • 6. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    World J Gastroenterol; 2005 Apr 28; 11(16):2431-7. PubMed ID: 15832413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Yu CC, Ko FY, Yu CS, Lin CC, Huang YP, Yang JS, Lin JP, Chung JG.
    Int J Oncol; 2012 Sep 28; 41(3):1050-60. PubMed ID: 22684608
    [Abstract] [Full Text] [Related]

  • 12. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Int J Oncol; 2012 May 28; 40(5):1501-14. PubMed ID: 22200632
    [Abstract] [Full Text] [Related]

  • 13. [Effect of norcantharidin's derivative Nd3 on proliferation of human ovarian cancer cell line SKOV3 and its possible mechanisms].
    Cao JH, Xu B, Li M, Wu DZ, Huang W, Cui JR.
    Ai Zheng; 2007 Apr 28; 26(4):361-6. PubMed ID: 17430652
    [Abstract] [Full Text] [Related]

  • 14. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
    Liu Y, Zahng J, You Z, Liao H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug 28; 30(8):824-8. PubMed ID: 25108435
    [Abstract] [Full Text] [Related]

  • 15. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Chen YJ, Kuo CD, Tsai YM, Yu CC, Wang GS, Liao HF.
    Anticancer Drugs; 2008 Jan 28; 19(1):55-64. PubMed ID: 18043130
    [Abstract] [Full Text] [Related]

  • 16. Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells.
    Ye K, Wei Q, Gong Z, Huang Y, Liu H, Li Y, Peng X.
    Ren Fail; 2017 Nov 28; 39(1):458-464. PubMed ID: 28393592
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
    Wang H, Sun W, Zhang WZ, Ge CY, Zhang JT, Liu ZY, Fan YZ.
    PLoS One; 2014 Nov 28; 9(5):e96982. PubMed ID: 24811250
    [Abstract] [Full Text] [Related]

  • 18. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
    Wang Y, Xu M, Di ZH, Zhang J, Mao XQ, Sun HB.
    J Cancer Res Ther; 2015 Nov 28; 11(4):818-22. PubMed ID: 26881524
    [Abstract] [Full Text] [Related]

  • 19. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP, Jing W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ.
    BMC Cancer; 2015 Jul 19; 15():527. PubMed ID: 26187792
    [Abstract] [Full Text] [Related]

  • 20. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma.
    Yang H, Guo W, Xu B, Li M, Cui J.
    Anticancer Drugs; 2007 Nov 19; 18(10):1133-7. PubMed ID: 17893513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.